DR. ALTHEA 345 Relief Cream Mask (1pc or 4 pcs)

Deliver instant relief to stressed, post-breakout skin with DR. ALTHEA’s 345 Relief Cream Mask, a soothing, cream-infused sheet mask designed to rapidly calm irritation, replenish moisture, and support skin recovery – especially after breakouts or external stress. Inspired by the brand’s cult-favourite 345 Relief Cream, this mask delivers the same comforting care in an intensive, skin-hugging treatment. The formula is built around Dr.

Althea’s 3-4-5 complex: 3 blemish-relief ingredients, 4 nourishing ingredients, and 5 soothing care ingredients working in perfect harmony to restore balance and resilience. Clinically proven to boost hydration and reduce visible redness after just one use*, it’s ideal for skin that feels inflamed, sensitised, or compromised. Soothing takes centre stage with 30% Tea Tree Leaf Water, known for its calming and clarifying benefits, alongside Centella Asiatica Leaf Water and Centella-derived actives like Madecassoside, which help relieve redness and support skin repair. These are complemented by Green Tea Leaf Water and PDRN to further calm irritation and strengthen the skin.

For blemish care and tone refinement, Niacinamide helps regulate sebum and brighten, Resveratrol targets post-acne marks, and Pantothenic Acid supports healing and reduces inflammation – addressing both active breakouts and their aftermath. Hydration and barrier support come from a nourishing blend of Ceramide NP, Hydrolysed Hyaluronic Acid, Beta-Glucan, and PDRN, delivering immediate moisture while reinforcing the skin barrier to prevent future dehydration and sensitivity. The high-adherence vegan cellulose sheet fits comfortably to the skin, allowing active ingredients to absorb deeply and evenly. With its creamy yet non-greasy essence, the mask leaves skin feeling soft, bouncy, and comforted – never heavy or sticky.

Dermatologically tested and suitable for sensitive skin, it’s the perfect reset when your complexion needs calming care. *According to results obtained in clinical trials conducted by Korea Institute of Dermatological Sciences on 15/9/2025, involving 22 adult subjects aged between 33 and 65.